Quantbot Technologies LP Has $5.57 Million Stake in Molina Healthcare, Inc. (NYSE:MOH)

Quantbot Technologies LP raised its stake in Molina Healthcare, Inc. (NYSE:MOH) by 223.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 19,144 shares of the company’s stock after acquiring an additional 13,217 shares during the period. Quantbot Technologies LP’s holdings in Molina Healthcare were worth $5,572,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. State Street Corp grew its holdings in shares of Molina Healthcare by 0.5% in the 3rd quarter. State Street Corp now owns 2,614,311 shares of the company’s stock worth $900,787,000 after purchasing an additional 13,001 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in Molina Healthcare by 2.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 400,080 shares of the company’s stock worth $116,443,000 after buying an additional 10,002 shares during the last quarter. Los Angeles Capital Management LLC increased its holdings in shares of Molina Healthcare by 166.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 196,513 shares of the company’s stock worth $57,195,000 after buying an additional 122,674 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Molina Healthcare by 2.2% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 149,573 shares of the company’s stock valued at $43,533,000 after acquiring an additional 3,238 shares during the last quarter. Finally, Victory Capital Management Inc. boosted its holdings in shares of Molina Healthcare by 48.9% in the 4th quarter. Victory Capital Management Inc. now owns 141,184 shares of the company’s stock worth $41,092,000 after acquiring an additional 46,350 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the sale, the director now owns 17,375 shares in the company, valued at $5,235,608.75. This represents a 5.44 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.10% of the company’s stock.

Molina Healthcare Stock Performance

Shares of Molina Healthcare stock opened at $309.85 on Friday. Molina Healthcare, Inc. has a 52 week low of $262.32 and a 52 week high of $423.92. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The stock has a market capitalization of $17.20 billion, a price-to-earnings ratio of 15.17, a PEG ratio of 1.06 and a beta of 0.56. The firm has a fifty day moving average of $299.99 and a two-hundred day moving average of $309.69.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. As a group, equities research analysts predict that Molina Healthcare, Inc. will post 24.4 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on MOH. Wells Fargo & Company raised Molina Healthcare from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $295.00 to $372.00 in a report on Wednesday, March 5th. StockNews.com downgraded shares of Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Monday, March 10th. Truist Financial lowered their price objective on shares of Molina Healthcare from $370.00 to $340.00 and set a “buy” rating for the company in a research report on Wednesday, February 19th. Stephens reiterated an “equal weight” rating and set a $345.00 target price on shares of Molina Healthcare in a research report on Thursday, February 6th. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and issued a $350.00 price target (down previously from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Molina Healthcare has an average rating of “Hold” and an average target price of $355.69.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.